Greek Media Uncovers the Reality of the Situation Between Thrivest, Ellington, and Attica Bank
ATHENS, Greece, Aug. 2, 2023 /PRNewswire/ -- Various legitimate sources have praised the Greek newspaper Kathimerini for publishing an article that impartially and objectively presents the history of Ellington Management Group's & Ellington Solutions' involvement with Attica Bank.
The article, amongst other things, mentions the existence of confidential agreements between Ellington and Thrivest Holdings.
Unlike other Greek media outlets that have been publishing inaccurate, and likely biased news articles since June 2023, Kathimerini's reporting on the matter has been refreshingly fair and factual.
Ellington expresses satisfaction with this reporting and remains committed to resolving the situation with all parties involved, but will not be providing further comments at this time.
SAP SE today announced NEC Corporation (TSE: 6701 "NEC") has selected SAP S/4HANA Cloud through the RISE with SAP solution, running on Amazon Web Services (AWS). Together with implementation partner ABeam Consulting, the migration will leverage...
Foundry 415 Innovation Group has unveiled its new Startup BoostCamp workshop series designed to empower startups with the knowledge and strategies they need to overcome the most common challenges to scaling and achieving success in the US market....
Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. ...
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....
ZIMLog, a global freight forwarding brand, proudly unveils its renewed structure, reflecting a blend of experience and innovation aimed at meeting the diverse and evolving needs of businesses worldwide.
After more than 22 years of successful...
Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980...
